Oppenheimer Sees 215% Upside in Viking Therapeutics as VK2735 Options Expand Beyond Near-Term Readouts
Wall Street stays bullish on VKTX as Oppenheimer sees expanded opportunities for VK2735 beyond near-term readouts and funding into 2028.
NOTRELOAD AI
Alibaba Unveils Qwen3.8-Max: Its Most Powerful AI Model Yet as Shares Rally
Shares rise as it rivals Anthropic’s Fable 5.
Curium to Acquire Lantheus in Up to $8 Billion Radiopharma Deal
Curium will buy Lantheus for $102.50/share cash plus up to $12 CVRs, valuing the radiopharma deal at up to $8B. Closing expected in H1 2027.
Supernus and Indivior Agree to Merge, Creating $2.2 Billion CNS Biopharma Leader
Supernus and Indivior merge to form a diversified CNS biopharma powerhouse with $2.2B revenue, $125M annual synergies, and greater growth flexibility.
KKR to Buy Integer Holdings for $5.7 Billion in All-Cash Deal
Shareholders get cash; company goes private by year-end.
GameStop Swaps $1.4 Billion of Debt for Stock in Dilutive Exchange
GameStop trades $1.4B zero-interest notes for equity. Debt drops, shares increase.